Shelter Pharma Ltd

The order comprises 2,000 boxes of Feedmin Bolus valued at $2,700, 2,500 boxes of Regulin Bolus worth $3,375, 1,200 pieces of Lactocal Gel valued at $3,360, and 1,500 boxes of Buta-B Bolus worth $2,850. The company said the order was received in the normal course of business and will be executed within mutually agreed timelines as per the purchase order schedule. Shelter Pharma clarified that neither its promoters nor the promoter group has any interest in Genet International. It also said the transaction does not qualify as a related-party transaction. Shelter Pharma manufactures pharmaceutical products, including herbal medicines for veterinary, poultry and human healthcare. The company's profit after tax (PAT) climbed 24.72% to Rs 9.03 crore in FY2026 from Rs 7.24 crore in FY2025, while net sales increased 44.35% year-on-year to Rs 73.13 crore. Powered by Capital Market - Live

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Shelter Pharma has secured an order from Taha Drugs & Chemicals Co., Sudan for Joemega Capsule and All Vitamins tablet, total order worth $ 1,44,000.

The company has appointed a Zonal Sales Manager for its veterinary division, along with a Regional Sales Manager for Uttarakhand and Western Uttar Pradesh. It has also added multiple sales officers across Gujarat and Rajasthan to enhance its field presence. In addition, an export executive has been appointed at the head office to support international business development. According to the company, the appointments are part of its strategy to strengthen its sales hierarchy, improve operational efficiency, and expand market reach across regions. The move is also expected to support growth in export markets alongside domestic expansion. Shelter Pharma is a pharmaceutical manufacturing company, specializing in herbal remedies for both human and veterinary healthcare. The company's standalone net profit jumped 27.12% to Rs 4.50 crore on 38.36% rise in net sales to Rs 33.29 crore in the half year ended September 2025 over the half year ended September 2024.

The order, valued at $18,300, is to be executed within six months, the company said in a regulatory filing. The contract has been awarded by an international entity and is on a fixed-cost basis. Shelter Pharma added that neither the promoter nor the promoter group has any interest in the entity awarding the order. The company also clarified that the transaction does not fall under related party transactions. Shelter Pharma is engaged in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. On a full year basis, the company's standalone net profit jumped 16.8% to Rs 7.24 crore on 26.6% rise in net sales to Rs 50.66 crore in FY25 over FY24. Powered by Capital Market - Live

Shelter Pharma has secured an order from Taha Drugs & Chemicals Co., Sudan for Joemega Capsule 3*10 Strips (BOX) total order worth 1,41,600 $. Powered by Capital Market - Live

The order is a fixed-cost contract and is to be executed within two months. The company said neither its promoters nor group companies have any interest in the entity awarding the contract. The transaction does not fall under related party transactions. Shelter Pharma is engaged in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. On a full year basis, the company's standalone net profit jumped 16.8% to Rs 7.24 crore on 26.6% rise in net sales to Rs 50.66 crore in FY25 over FY24. Powered by Capital Market - Live

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live

Shelter Pharma announced that the 18th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live

Shelter Pharma announced that the Board of Directors of the Company at its meeting held on 2 September 2025, inter alia, have recommended the final dividend of Rs 0.35 per equity Share (i.e. 3.5%) , subject to the approval of the shareholders.Powered by Capital Market - Live